Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Fungal Biol.

Sec. Medical Mycology

This article is part of the Research TopicNew Advances in Candida Infections: Pathogenesis, Diagnosis, and TreatmentView all articles

Phenotypic and genomic characterization of azole resistance in Portuguese Candida parapsilosis isolates

Provisionally accepted
  • 1Reference Unit for Parasitic and Fungal Infections, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016, Lisbon, Portugal
  • 2Microbiology Laboratory, Unidade Local de Saúde Lisboa Ocidental, Hospital Egas Moniz, 1349-019, Lisbon, Portugal
  • 3Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016, Lisbon, Portugal
  • 4Animal and Veterinary Research Center (CECAV), Faculty of Veterinary Medicine, Lusófona University - Lisbon University Centre, Lisbon, Portugal
  • 5Faculdade de Farmácia, Universidade de Lisboa, 1649-003, Lisbon, Portugal
  • 6Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, 1649-028, Lisbon, Portugal
  • 7Laboratório Associado TERRA, Instituto Superior de Agronomia, Tapada da Ajuda, 1349-017, Lisbon, Portugal

The final, formatted version of the article will be published soon.

Candida parapsilosis is a clinically important etiological agent of systemic infections associated with hospital outbreaks, which prevalence has been increasing in the last decade. Moreover, in recent years, fluconazole resistance in this species has been emerging in different countries, being a subject of significant interest and concern. In this context, the present study aims to determine the frequency of fluconazole resistance in C. parapsilosis sensu stricto isolates collected in Portugal (2003-2007 and 2017-2024), understand its associated molecular mechanisms, and relate it all with worldwide genomic data. To this end, we performed phenotypic assays of 145 isolates of C. parapsilosis collected from different biological and environmental products in Portugal (majority from the Lisbon Metropolitan area), and explored the genomic features of the fluconazole-resistant ones. We found eight C. parapsilosis fluconazole-resistant isolates between 2017 and 2024, corresponding to a frequency of 8.5% in this period, and contrasting with the absence of fluconazole-resistant isolates collected before 2007. Sequencing of the ERG11 gene showed that all fluconazole-resistant isolates had the Y132F and R398I mutations. A phylogenomic analysis including publicly available isolates from other countries revealed that our Portuguese isolates are more closely related to those from the USA and Germany than to the isolates sequenced thus far from the neighbor country, Spain. Furthermore, although three distinct C. parapsilosis genetic clades were found in our dataset, all the fluconazole-resistant isolates detected in this study cluster together, raising the question of whether the increased fluconazole-resistance in the country could possibly be associated with the emergence or introduction of this particular lineage. Altogether, these results provide valuable insights on fluconazole resistance in a set of Portuguese C. parapsilosis isolates and their associated mechanisms, representing an important step towards a better understanding of the increasing C. parapsilosis fluconazole resistance in Southern Europe.

Keywords: Candida parapsilosis, Resistance, Fluconazole, ERG11, Whole-genomesequencing

Received: 26 Sep 2025; Accepted: 21 Nov 2025.

Copyright: © 2025 Papuc, Veríssimo, Simões, Toscano, Gomes, Mixão and Sabino. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Verónica Mixão, veronica.mixao@insa.min-saude.pt
Raquel Sabino, raquel.sabino@ff.ulisboa.pt

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.